# FDA Inspection 1063657 - Carter BloodCare - August 15, 2018

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/e9528bc8-79a5-4ccb-984b-b3194822a045
Source feed: FDA_Inspections

> FDA Inspection 1063657 for Carter BloodCare on August 15, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063657
- Company Name: Carter BloodCare
- Inspection Date: 2018-08-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257853 - 2024-12-04](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/ee81ccf8-1b79-402e-a7d7-7455b4566874)
- [FDA Inspection 1257853 - 2024-12-04](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/ee05afcd-4b1f-42b6-bcdc-36b8cecc58b9)
- [FDA Inspection 1210114 - 2023-06-14](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/182c01b4-a170-47d0-9fa0-1467ac05e837)
- [FDA Inspection 963720 - 2016-01-13](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/6848a688-1ccf-42cb-8e84-9f6de490e21a)
- [FDA Inspection 865335 - 2014-02-04](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/184fa1f6-9105-48a0-99a5-b2251b9417a8)

Company: https://www.keypedia.com/companies/carter-bloodcare/a54c2982-1796-4788-b533-2369461510e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d